These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38550817)
21. Uncommon Presentation of a Common Histiocytic Tumor: A Rare Entity. Kar C; Das K; Barua JK Indian J Dermatol; 2015; 60(3):301-4. PubMed ID: 26120163 [TBL] [Abstract][Full Text] [Related]
22. Eruptive xanthogranuloma in a healthy adult male. Ederle A; Kim KH; Gardner JM J Cutan Pathol; 2017 Apr; 44(4):385-387. PubMed ID: 28000234 [TBL] [Abstract][Full Text] [Related]
23. Benign cephalic histiocytosis progressing into juvenile xanthogranuloma: a non-Langerhans cell histiocytosis transforming under the influence of a virus? Rodriguez-Jurado R; Duran-McKinster C; Ruiz-Maldonado R Am J Dermatopathol; 2000 Feb; 22(1):70-4. PubMed ID: 10698221 [TBL] [Abstract][Full Text] [Related]
24. Concomitant adult onset xanthogranuloma and IgG4-related orbital disease: a rare occurrence. Andron AA; Nair AG; Della Rocca D; Della Rocca RC; Reddy HS Orbit; 2022 Feb; 41(1):108-111. PubMed ID: 32847452 [TBL] [Abstract][Full Text] [Related]
25. TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease. Ding X; Cao Y; Xing Y; Ge S; Lin M; Li J Ocul Immunol Inflamm; 2020; 28(2):288-297. PubMed ID: 30973282 [No Abstract] [Full Text] [Related]
30. Cutaneous adult xanthogranuloma with a small portion of BRAF Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719 [TBL] [Abstract][Full Text] [Related]
31. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Karcioglu ZA; Sharara N; Boles TL; Nasr AM Ophthalmic Plast Reconstr Surg; 2003 Sep; 19(5):372-81. PubMed ID: 14506422 [TBL] [Abstract][Full Text] [Related]
38. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Salari B; Dehner LP Ann Diagn Pathol; 2022 Jun; 58():151940. PubMed ID: 35378409 [TBL] [Abstract][Full Text] [Related]
39. Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations. Detiger SE; Paridaens D; Kemps PG; van Halteren AGS; van Hagen PM; van Laar JAM; Verdijk RM Clin Immunol; 2024 Aug; 265():110299. PubMed ID: 38936524 [TBL] [Abstract][Full Text] [Related]
40. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports. Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]